top of page

Video Channels

FEATURED VIDEOS

What is Ocular Melanoma?

Through The Lens Of An Ocular Oncologist: What is Ocular Melanoma?

AIMatMelanoma
Through The Lens Of An Ocular Oncologist: What is Ocular Melanoma?
Through The Lens Of An Ocular Oncologist: What is Ocular Melanoma?
20:41

Through The Lens Of An Ocular Oncologist: What is Ocular Melanoma?

AIMatMelanoma
Uveal Melanoma with Liver Metastases: Patient Experience, Treatment Challenges & Hope on the Horizon
04:53

Uveal Melanoma with Liver Metastases: Patient Experience, Treatment Challenges & Hope on the Horizon

TriSalus Life Sciences
Uveal Melanoma 2022 | C. Shields
38:47

Uveal Melanoma 2022 | C. Shields

Νοσοκομείο Υγεία
Uveal Melanoma, A Modern Approach to Ocular Oncology | Tara McCannel, MD | UCLAMDChat
28:43

Uveal Melanoma, A Modern Approach to Ocular Oncology | Tara McCannel, MD | UCLAMDChat

UCLA Health
Choroidal Melanoma
09:27

Choroidal Melanoma

Moran CORE
Ocular Melanoma - See Your Eye Professional Today
02:44

Ocular Melanoma - See Your Eye Professional Today

Ocular Melanoma Foundation
Meeting at the office
Meeting at the office
FEATURED CHANNELS
Meeting at the office

Can cancer treatment impact my eyes and vision?

Many cancer treatments can affect your eyes and vision in a variety of ways. Some mild eye-related side effects, such as dryness or blurred vision, can resolve on their own, but serious side effects can impact your vision in the long term.

112024 Cancer Today.jpg
What is mUM Kimmtrak.jpg
Meeting at the office
American Society of Retina Specialists banner.png

American Society of Retina Specialists

Bilateral Peripheral Neovascularization in Hemoglobin C Trait Retinopathy

ASRS_American Society of Retina Specialists
Bilateral Peripheral Neovascularization in Hemoglobin C Trait Retinopathy
Bilateral Peripheral Neovascularization in Hemoglobin C Trait Retinopathy
11:51

Bilateral Peripheral Neovascularization in Hemoglobin C Trait Retinopathy

ASRS_American Society of Retina Specialists
Short-Term Changes in Intraocular Pressure Following Intravitreal Injection of Pegcetacoplan
13:01

Short-Term Changes in Intraocular Pressure Following Intravitreal Injection of Pegcetacoplan

ASRS_American Society of Retina Specialists
ASRS Leaders & Legends Interview: Evangelos S. Gragoudas, MD
31:08

ASRS Leaders & Legends Interview: Evangelos S. Gragoudas, MD

ASRS_American Society of Retina Specialists
Meeting at the office
The Eye Cancer Foundation banner.jpg

The mission of The Eye Cancer Foundation is three-fold: to develop and encourage international, multi-center research on new diagnostic treatments; to provide much-needed support services for patients and their families; and to save lives through our international fellowship program by training doctors in underserved and unserved countries.

It has been our goal to create a world-class resource for patients and their families diagnosed with eye cancer in the form of ocular tumors, macular degeneration, and related ophthalmic conditions. We want to help you, your children and families around the world. 

The Eye Cancer Foundation

Dr. Finger's 2025 Zimmerman Lecture at the American Academy of Ophthalmology

The Eye Cancer Foundation
Dr. Finger's 2025 Zimmerman Lecture at the American Academy of Ophthalmology
Dr. Finger's 2025 Zimmerman Lecture at the American Academy of Ophthalmology
33:08

Dr. Finger's 2025 Zimmerman Lecture at the American Academy of Ophthalmology

The Eye Cancer Foundation
2023 ISOO Fellow Presentations: Day 3
20:16

2023 ISOO Fellow Presentations: Day 3

The Eye Cancer Foundation
2023 ISOO Fellow Presentations: Day 2
17:33

2023 ISOO Fellow Presentations: Day 2

The Eye Cancer Foundation
Meeting at the office
Tara McCannel banner.jpg

Finding Your Way With Ocular Melanoma

Will I Wear Out My Better Seeing Eye? Breaking the Myth

Tara McCannel, MD PhD | Ocular Melanoma
Will I Wear Out My Better Seeing Eye? Breaking the Myth
Will I Wear Out My Better Seeing Eye? Breaking the Myth
13:56

Will I Wear Out My Better Seeing Eye? Breaking the Myth

Tara McCannel, MD PhD | Ocular Melanoma
One-Page OcularMelanoma "START HERE" Guide
18:11

One-Page OcularMelanoma "START HERE" Guide

Tara McCannel, MD PhD | Ocular Melanoma
When Is The Best Time To Get New Glasses After Eye Surgery?
06:32

When Is The Best Time To Get New Glasses After Eye Surgery?

Tara McCannel, MD PhD | Ocular Melanoma
Tara McCannel webinar event info.png
Meeting at the office
Melanoma Research Alliance logo blk bkg.png
The Melanoma Research Alliance

Advancing Discoveries,

Changing Lives, Curing Melanoma.

MRA is the world’s largest private nonprofit funder of melanoma research.

We’ve directly invested over $175 million toward scientific discoveries,

and we won’t stop until we achieve our mission of curing melanoma.

MelanomaReAlli

Compassionate Use in Melanoma & the Emerging RP1 Therapy

MelanomaReAlli
Compassionate Use in Melanoma & the Emerging RP1 Therapy
Compassionate Use in Melanoma & the Emerging RP1 Therapy
40:36

Compassionate Use in Melanoma & the Emerging RP1 Therapy

MelanomaReAlli
The Life of a Melanoma Patient Sample
44:28

The Life of a Melanoma Patient Sample

MelanomaReAlli
Melanoma Risk Speed Talk: Hereditary Risk
21:28

Melanoma Risk Speed Talk: Hereditary Risk

MelanomaReAlli
Meeting at the office
Melanoma Research Foundation logo.png
Melanoma Research Foundation Banner.jpg
CURE OM (the Community United for Research and Education of Ocular Melanoma) is the MRF’s initiative to increase awareness, education and research funding for ocular melanoma, while improving the lives of people affected by this disease. Founded in 2011, the CURE OM initiative excels because of the hard work and dedication of its Patient and Scientific Steering Committees and the generosity of our community.
Melanoma Research Foundation Ocular Melanoma Fact Sheet image.jpg
Melanoma Research Foundation Ask A Nurse image.jpg

Cure Melanoma

Ask the Expert: Discussing the Past, Present and Future of Cell-based Immune Treatments for Melanoma

Cure Melanoma
Ask the Expert: Discussing the Past, Present and Future of Cell-based Immune Treatments for Melanoma
Ask the Expert: Discussing the Past, Present and Future of Cell-based Immune Treatments for Melanoma
01:33:01

Ask the Expert: Discussing the Past, Present and Future of Cell-based Immune Treatments for Melanoma

Cure Melanoma
Exploring Tumor-Infiltrating Lymphocyte (TIL) Therapy With Lindsay Held
17:32

Exploring Tumor-Infiltrating Lymphocyte (TIL) Therapy With Lindsay Held

Cure Melanoma
2026 Advocacy Days: Amy Jardon
00:42

2026 Advocacy Days: Amy Jardon

Cure Melanoma
Meeting at the office
Nord banner.jpg
Nord EVENT Rare Disease Scientific Symposium banner.png
Nord logo.png

Ocular Melanoma

Last updated: 8/20/2024
Years published: 2018, 2024

Full Report Link @ https://rarediseases.org/rare-diseases/ocular-melanoma/

Acknowledgment

NORD gratefully acknowledges Gioconda Alyea, MD (FMG), MS, National Organization for Rare Disorders, Prithvi Mruthyunjaya, MD, MHS, Associate Professor of Ophthalmology, Ocular Oncology and Vitreoretinal Surgery; Director, Ocular Oncology Service, Byers Eye Institute at Stanford, and the Ocular Melanoma Foundation, for assistance in the preparation of this report.

Disease Overview

Summary

Ocular melanoma is an extremely rare type of cancer that occurs in about 5 out of every million adults. Despite its rarity, it is the most common primary cancer of the eye in adults. A primary cancer means that the cancer begins in the eye itself and has not spread there from another part of the body. The exact cause of ocular melanoma is unknown, but several risk factors have been identified, including genetic factors and possibly environmental influences. Despite this uncertainty, early detection and treatment are crucial for the best outcomes.

Introduction

Eye (ocular) cancer can refer to any cancer that starts in the eye.

The eye is a complex organ with three main parts:

  1. Eyeball (globe): The main part of the eye, filled with a jelly-like substance called vitreous humor. It has three layers:

    • Sclera: The tough, white outer layer

    • Uvea: The middle layer, responsible for nourishment and containing the eye’s pigmented cells

    • Retina: The innermost layer, which senses light and is crucial for vision

  2. Orbit: The tissues surrounding the eyeball

  3. Adnexal structures: These include accessory parts like the eyelids and tear glands

Different types of cancer can develop in these areas depending on the type of cells involved. Ocular melanoma typically arises from cells called melanocytes, which produce pigment. When these melanocytes in the choroid become cancerous, the condition is known as choroidal or uveal melanoma. Although these melanocytes are similar to those in the skin, skin melanoma and ocular melanoma are distinct conditions, each with different biological and genetic characteristics. It is rare for skin melanoma to spread to the eye or vice versa.

Uveal melanomas

Ocular melanoma can start at the uveal tract, the colored layer of tissue beneath the white of the eye (sclera). The uvea consists of three parts:

  1. Iris: The colored part of the eye which surrounds the pupil

  2. Ciliary body: A ring of muscle tissue that releases aqueous humor (a clear fluid) and helps control the lens’s shape for focusing

  3. Choroid: The largest part of the uveal tract, located at the back of the eye beneath the retina. This area is rich in blood vessels and pigmented cells.

Most ocular melanomas develop in the choroid or ciliary body. About 9 out of 10 intraocular melanomas occur in these areas. Iris melanomas are less common and usually easier to detect because they often start as a dark spot on the iris that grows over time. Iris melanomas are generally slow-growing and rarely spread, leading to a relatively good prognosis.

Uveal melanomas can spread through the bloodstream, most often reaching the liver, where the cancer can become life-threatening.

 

Conjunctival melanomas

The conjunctiva is a thin, clear layer covering the sclera. Conjunctival melanomas are extremely rare but tend to be more aggressive. They can grow into nearby structures and spread through both the blood and lymphatic systems, reaching distant organs like the lungs, liver or brain.

Full Report Link @ https://rarediseases.org/rare-diseases/ocular-melanoma/

National Organization for Rare Disorders (NORD)

Keynote Address: Tracy Beth Høeg (FDA CDER Acting Director) - NORD Scientific Symposium

National Organization for Rare Disorders (NORD)
Keynote Address: Tracy Beth Høeg (FDA CDER Acting Director) - NORD Scientific Symposium
Keynote Address: Tracy Beth Høeg (FDA CDER Acting Director) - NORD Scientific Symposium
20:52

Keynote Address: Tracy Beth Høeg (FDA CDER Acting Director) - NORD Scientific Symposium

National Organization for Rare Disorders (NORD)
Why the NORD Symposium Is Where Connections Happen
00:40

Why the NORD Symposium Is Where Connections Happen

National Organization for Rare Disorders (NORD)
NORD Symposium 2026: Why You Should Attend
00:54

NORD Symposium 2026: Why You Should Attend

National Organization for Rare Disorders (NORD)
Nord logo.png
Meeting at the office
Opthamology Innovation Source logo.jpg
OIS has set the benchmark for excellence in eye care innovation by uniting pioneering startups, leading strategics, top investors, and renowned clinicians. More than a conference, OIS is a trusted community where ideas take root, partnerships are born, and the future of ophthalmology is shaped. With expertly curated programming, exclusive networking opportunities, and unmatched access to breakthrough technologies, OIS empowers industry leaders to make impactful decisions and build relationships that last.

OIS: Ophthalmology Innovation Source

OIS Podcast Ep #428: How Interventional Glaucoma is Advancing Eye Care

OIS: Ophthalmology Innovation Source
OIS Podcast Ep #428: How Interventional Glaucoma is Advancing Eye Care
OIS Podcast Ep #428: How Interventional Glaucoma is Advancing Eye Care
15:58

OIS Podcast Ep #428: How Interventional Glaucoma is Advancing Eye Care

OIS: Ophthalmology Innovation Source
OIS Podcast Ep #427: Tackling New Territory and Forming Partnerships
15:29

OIS Podcast Ep #427: Tackling New Territory and Forming Partnerships

OIS: Ophthalmology Innovation Source
OIS Podcast Ep #426: Malvina Eydelman and the Bright Future of Innovation for Ophthalmology
23:57

OIS Podcast Ep #426: Malvina Eydelman and the Bright Future of Innovation for Ophthalmology

OIS: Ophthalmology Innovation Source
Meeting at the office
Ocular Melanoma Foundation logo.jpeg
Ocular Melanoma Foundation banner 1.jpg

Ocular Melanoma Foundation is raising funds, engaging academicians and clinicians, and actively partnering with foundations and other leading agencies supporting cancer research to:
 

1.  Support and accelerate scientific research and discovery and its translation into effective treatment options for patients.

2.  Provide resources for education and support to OM patients, their families, and to healthcare professionals treating OM.

3.  Act as an advocate within the melanoma and broader cancer community to raise the awareness of OM and the need for a cure.

Ocular Melanoma Foundation

Liver-Directed Therapies: Percutaneous Hepatic Perfusion, Dr. Faries & Dr. Hwong

Ocular Melanoma Foundation
Liver-Directed Therapies: Percutaneous Hepatic Perfusion, Dr. Faries & Dr. Hwong
Liver-Directed Therapies: Percutaneous Hepatic Perfusion, Dr. Faries & Dr. Hwong
40:41

Liver-Directed Therapies: Percutaneous Hepatic Perfusion, Dr. Faries & Dr. Hwong

Ocular Melanoma Foundation
Overview of Melanoma Gene Expression Profile (GEP) Test by Castle Biosciences
36:28

Overview of Melanoma Gene Expression Profile (GEP) Test by Castle Biosciences

Ocular Melanoma Foundation
Patient Q&A with Ocular Melanoma Experts, Dr. Damato, Hovland, Mruthyunjaya, Seider
35:31

Patient Q&A with Ocular Melanoma Experts, Dr. Damato, Hovland, Mruthyunjaya, Seider

Ocular Melanoma Foundation
2017 Eye Am Not Alone
Patient & Caregiver Conference

Hosted by Ocular Melanoma Foundation

2017 OMF EANA Patient & Caregiver Conference

Experience Battling Ocular Melanoma as a Patient and a Mother

Ocular Melanoma Foundation
Experience Battling Ocular Melanoma as a Patient and a Mother
Experience Battling Ocular Melanoma as a Patient and a Mother
10:28

Experience Battling Ocular Melanoma as a Patient and a Mother

Ocular Melanoma Foundation
Clinical Trials for Ocular Melanoma, Discussion with Drs. Mruthyunjaya, Dr. Patel, and Dr. Stecher
54:36

Clinical Trials for Ocular Melanoma, Discussion with Drs. Mruthyunjaya, Dr. Patel, and Dr. Stecher

Ocular Melanoma Foundation
Overview of Uveal Melanoma, Dr. Prithvi Mruthyunjaya
35:18

Overview of Uveal Melanoma, Dr. Prithvi Mruthyunjaya

Ocular Melanoma Foundation
Meeting at the office
Rare Cancer Research Foundation profile.jpg
Empowering Patiets Rare Cancer Research Alliance banner.jpg
The Rare Cancer Alliance

Accelerating Cures Through

Patient-Powered Collaboration

MRA is the world’s largest private nonprofit funder of melanoma research.

We’ve directly invested over $175 million toward scientific discoveries,

and we won’t stop until we achieve our mission of curing melanoma.

Rare Cancer Research Foundation

Pattern.org Walkthrough

Rare Cancer Research Foundation
Pattern.org Walkthrough
Pattern.org Walkthrough
04:06

Pattern.org Walkthrough

Rare Cancer Research Foundation
Dr. Jesse Boehm Discusses Importance of Rare Cancer Tissue Donation Through Pattern.org
02:01

Dr. Jesse Boehm Discusses Importance of Rare Cancer Tissue Donation Through Pattern.org

Rare Cancer Research Foundation
Accelerating Cancer Research: An Overview of The Rare Cancer Research Foundation
01:29

Accelerating Cancer Research: An Overview of The Rare Cancer Research Foundation

Rare Cancer Research Foundation
Meeting at the office
ENTERTAINMENT. Beyond Mishawaka.

Meeting at the office
092725 Ocular Melanoma Cancer Society LOGO TM + R white layer bkg.png
Navy Blue Baby Blue OM Awareness Ribbon 072325.png
Baby Blue Light Green Eye Cancer Awareness Ribbon.png

Our Mission:
The Ocular Melanoma Society is dedicated to raising awareness, advancing education, and empowering individuals impacted by Ocular Melanoma and all rare forms of eye cancer. We strive to promote early detection, support patients and caregivers, and advocate for research and treatment innovations - so that no one faces ocular cancer alone.

 

Our Goal:

To offers vital information, support, and resources for rare eye cancer patients and caregivers - affected by ocular melanoma, retinoblastoma, conjunctival melanoma, and intraocular lymphoma - all in one place. 

Together, WE empower patients to raise awareness.

Your Journey. Your Story. Your Strength. 

Your Support. Your Involvement.

Your Communication. Make A Difference.

  • Facebook
  • YouTube
  • Instagram
  • TikTok
Through The Lens Of An Ocular Oncologist: What is Ocular Melanoma?
BlueOMBlack.org Facebook Group
092725 Ocular Melanoma Cancer Society LOGO TM + R white layer bkg.png

Launched 07.10.2025

Baby Blue Light Green Eye Cancer Awareness Ribbon.png
Navy Blue Baby Blue OM Awareness Ribbon 072325.png
501c3 Organization for Eye Cancer Awareness
bottom of page